After more than a year of deliberation, the World Trade Organization appears close to rejecting a waiver on intellectual property protection for Covid-19 diagnostics and treatments, a divisive issue that has pitted low-income nations and civil society groups against medical products companies.
WTO appears close to rejecting a proposed waiver on patents for Covid diagnostics and therapies
